News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Generic manufacturers sign sublicence agreements with the Medicines Patent Pool to produce generic versions of Novartis’ nilotinib – Medicines Patent Pool
Photo from medicinespatentpool.org
Jun 22, 2023, 18:35

Generic manufacturers sign sublicence agreements with the Medicines Patent Pool to produce generic versions of Novartis’ nilotinib – Medicines Patent Pool

Breaking | 4 generic manufacturers sign sublicence agreements with the Medicines Patent Pool to produce generic versions of Novartis,’ nilotinib for the treatment of chronic myeloid leukaemia.
The four generic manufacturers companies include:

  1. Eugia Pharma Specialities Ltd (INDIA)
  2. Hetero (INDIA)
  3. Dr. Reddy’s Laboratories (INDIA)
  4. PT. Brightgene Biomedical Indonesia (INDONESIA)

 

Source:

cancer chronic myeloid leukaemia generic health for all India Indonesia Medicines Patent Pool nilotinib Novartis OncoDaily Pharma
Special Coverage
Blog
Jun 17, 2025, 07:29
CPD, University of Toronto - Emergent and Comprehensive Clinical Updates on Survivorship Care Conference
Blog
Jun 17, 2025, 07:22
Zainab Shinkafi-Bagudu: Cervical Cancer Elimination is Possible
Career
Jun 17, 2025, 07:21
SIOG and CARG have signed a Memorandum of Understanding
Blog
Jun 17, 2025, 07:17
Randiga Harnes: Cancer Survivorship Starts at Diagnosis - It Is Quite Simple, Really
Career
Jun 17, 2025, 07:17
Marty Taylor Has Been Selected As the 2025 Rita Allen Milton E. Cassel Scholar
Blog
Jun 17, 2025, 07:07
Registration is Open for EIOC Journal Club Webinar on "Post-ASCO Updates in the Management of Breast Cancer"
Blog
Jun 17, 2025, 06:58
Sergio Cifuentes Promotes International Acute Oncology Services Survey for Latin American Oncologists
Science
Jun 17, 2025, 06:57
Maria Gemelli: The Latest Meta-analysis on the Role of ICIs in PD-L1 Negative NSCLC
Opinion
Jun 17, 2025, 06:53
Matt Sagan: It’s a Great Time to Be Now in the Cancer Vaccines Space
Blog
Jun 17, 2025, 06:49
PSOGI - Peritoneal Surface Malignancy Video Workshop and Live Surgery
Blog
Jun 17, 2025, 06:44
Registration Is Open for the Uterine Cancers in the Molecular Era Webinar - IGCS
Blog
Jun 17, 2025, 06:38
The Summit on Cardio-Oncology Excellence 2025 - Maria Sklodowska-Curie National Research Institute of Oncology